The federal government is investing millions of new dollars to boost Canada’s domestic vaccine and drug development capacity.
Innovation Minister Francois-Philippe Champagne says Canada must build and expand homegrown biomanufacturing facilities and develop more equipment to secure more vaccines and therapeutics to combat COVID-19.
Ottawa will contribute up to $54.2 million to KABS Laboratories and up to $13.44 million to Immune Biosolutions to expand their respective operations in Quebec.
Get daily National news
It will also provide up to $32.7 million to Novocol Pharmeceutical of Canada for growth of its biomanufacturing facilities in Ontario.
- Jazz and gospel fill the church in Little Burgundy as Montreal honours Oliver Jones
- Summerland businesses face another blow as water advisory keeps doors closed
- Calgary’s tech sector sees North America’s highest growth 3 years and counting
- U.S. alcohol may go back on Manitoba shelves, but Kinew urges customers to buy Canadian
Ottawa is also investing $150 million to help companies advance through the early stages of research and development of several Canadian-made vaccine candidates.
Comments
Want to discuss? Please read our Commenting Policy first.